Article info
Commentary
Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension
- Correspondence to Dr Jonel Trebicka, Department of Internal Medicine I, University of Bonn, Sigmund-Freud-Str. 25, Bonn 53127, Germany; Jonel.trebicka{at}ukb.uni-bonn.de
Citation
Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension
Publication history
- Received December 19, 2014
- Accepted December 23, 2014
- First published January 16, 2015.
Online issue publication
August 07, 2015
Article Versions
- Previous version (16 January 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions